Diaphorina citri psyllid: psy13508

Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-
MAEATRSHLPALSEDDMDSWIVEGDKKLSIDNETKFCSPNLLKNVLQCVKGNGDVYDPENILSLHEFVMKSSKGRGVHFMMADGGFSVEGQENIQEILSKRLYLCQFLVSLFIVRPEGHFVCKVFDMFTPFSAGLLYLLYRSYKQVCIFKPNTSRPANSERYIVCKWKRPDCDTIRDFMFKLNKRLDRYGSTSKRDIVSCVPLDIMKSDANFFDYLVTSNNTVFDELEGDQFFRARNRSNPFELIKNGPFLNRAAMKMANMDKRLNSMFTQPVRENGNGPFLNRAAMKMANMDKRLNSMFTQPVRENGSPLLGPGELLYFADVCAGPGGFSEYVLYRKKWRAKGIGFTLTGSHDFKLDDFFAGPSETFEPYYGVKGNGDVYDPENILSLHEFVMKSTKGRGVHFMMADGGFSVEGQENIQEILSKRLYLCQFLVSLFIVRPEGHFVCKVFDMFTPFSAGLLYLLYRSYKQVCIFKPNTSRPANSERYIVCKWKRPDCDTIRDFMFKLNKRLDRYGSTSKRDIVSCVPLDIMKSDANFFDYLVTSNNVINRIAGLGKHAIYRYREDSNRWVSETSLGIQLSPGTLVYGETVEEFKGQGASQVKLKTFHIIDAYLITGRSQVK
ccHHHHccccccccccccccEEEccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccEEEccccccccccHHHHHHHHHHHHHHHHHHHHHHcccccCEEEEEccccccccHHHHHHHHccccEEEEEccccccccccHHHHHHccccccccHHHHHHHHHHHHHcccccccccccCECcccccccccccccHHHHHccccccccccHHHHHHHccccccccccccccHHHHHHHHHcccccccccccccHHHcccccccccHHHHHHHHHHHHcccccccccccccccccccccccEEEEEcccccHHHHHHHHcccccccCCcccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccEEEEEccccccccccccHHHHHHHHHHHHHHHHHHHHcccccCEEEEEccccccccHHHHHHHHccccEEEEEcccccccccccEEEEEccccccccHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHccccccccccccccccHHHHHHHHccccccccEEEHHHHHHHHHcccccccc
*********PALSEDDMDSWIVEGDKKLSIDNETKFCSPNLLKNVLQCVKGNGDVYDPENILSLHEFVMKSSKGRGVHFMMADGGFSVEGQENIQEILSKRLYLCQFLVSLFIVRPEGHFVCKVFDMFTPFSAGLLYLLYRSYKQVCIFKPNTSRPANSERYIVCKWKRPDCDTIRDFMFKLNKRLDRYGSTSKRDIVSCVPLDIMKSDANFFDYLVTSNNTVFDELEGDQFFRARNRSNPFELIKNGPFLNRAAMKMANMDKRLNSMFTQPVRENGNGPFLNRAAMKMANMDKRLNSMFTQPVRENGSPLLGPGELLYFADVCAGPGGFSEYVLYRKKWRAKGIGFTLTGSHDFKLDDFFAGPSETFEPYYGVKGNGDVYDPENILSLHEFVMKSTKGRGVHFMMADGGFSVEGQENIQEILSKRLYLCQFLVSLFIVRPEGHFVCKVFDMFTPFSAGLLYLLYRSYKQVCIFKPNTSRPANSERYIVCKWKRPDCDTIRDFMFKLNKRLDRYGSTSKRDIVSCVPLDIMKSDANFFDYLVTSNNVINRIAGLGKHAIYRYREDSNRWVSETSLGIQLSPGTLVYGETVEEFKGQGASQVKLKTFHIIDAYLITGRS***
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MAEATRSHLPALSEDDMDSWIVEGDKKLSIDNETKFCSPNLLKNVLQCVKGNGDVYDPENILSLHEFVMKSSKGRGVHFMMADGGFSVEGQENIQEILSKRLYLCQFLVSLFIVRPEGHFVCKVFDMFTPFSAGLLYLLYRSYKQVCIFKPNTSRPANSERYIVCKWKRPDCDTIRDFMFKLNKRLDRYGSTSKRDIVSCVPLDIMKSDANFFDYLVTSNNTVFDELEGDQFFRARNRSNPFELIKNGPFLNRAAMKMANMDKRLNSMFTQPVRENGNGPFLNRAAMKMANMDKRLNSMFTQPVRENGSPLLGPGELLYFADVCAGPGGFSEYVLYRKKWRAKGIGFTLTGSHDFKLDDFFAGPSETFEPYYGVKGNGDVYDPENILSLHEFVMKSTKGRGVHFMMADGGFSVEGQENIQEILSKRLYLCQFLVSLFIVRPEGHFVCKVFDMFTPFSAGLLYLLYRSYKQVCIFKPNTSRPANSERYIVCKWKRPDCDTIRDFMFKLNKRLDRYGSTSKRDIVSCVPLDIMKSDANFFDYLVTSNNVINRIAGLGKHAIYRYREDSNRWVSETSLGIQLSPGTLVYGETVEEFKGQGASQVKLKTFHIIDAYLITGRSQVK

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 S-adenosyl-L-methionine-dependent methyltransferase that mediates mRNA cap1 2'-O-ribose methylation to the 5'-cap structure of mRNAs. Methylates the ribose of the first nucleotide of a m(7)GpppG-capped mRNA to produce m(7)GpppNmp (cap1). Cap1 modification is linked to higher levels of translation.confidentQ9DBC3
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 S-adenosyl-L-methionine-dependent methyltransferase that mediates mRNA cap1 2'-O-ribose methylation to the 5'-cap structure of mRNAs. Methylates the ribose of the first nucleotide of a m(7)GpppG-capped mRNA to produce m(7)GpppNmp (cap1). Cap1 modification is linked to higher levels of translation.confidentQ803R5
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 S-adenosyl-L-methionine-dependent methyltransferase that mediates mRNA cap1 2'-O-ribose methylation to the 5'-cap structure of mRNAs. Methylates the ribose of the first nucleotide of a m(7)GpppG-capped mRNA to produce m(7)GpppNmp (cap1). Cap1 modification is linked to higher levels of translation.confidentD2HRF1

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0080009 [BP]mRNA methylationprobableGO:0009451, GO:0090304, GO:0034641, GO:0006807, GO:1901360, GO:0006139, GO:0044260, GO:0016556, GO:0071704, GO:0032259, GO:0044238, GO:0009987, GO:0006725, GO:0043412, GO:0043414, GO:0008152, GO:0001510, GO:0046483, GO:0016070, GO:0016071, GO:0044237, GO:0043170, GO:0008150
GO:0005737 [CC]cytoplasmprobableGO:0044424, GO:0005575, GO:0044464, GO:0005623, GO:0005622
GO:0005730 [CC]nucleolusprobableGO:0005575, GO:0043232, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0043228, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0004483 [MF]mRNA (nucleoside-2'-O-)-methyltransferase activityprobableGO:0003824, GO:0008757, GO:0016740, GO:0008173, GO:0008171, GO:0016741, GO:0003674, GO:0008174, GO:0008168

Prediction of Enzyme Commission Number ?

No confident prediction of EC number!

Spatial Structural Prediction

Structural Models Based on Templates

Template: 3EVF, chain A
Confidence level:very confident
Coverage over the Query: 216-261,277-298,312-382,395-511
View the alignment between query and template
View the model in PyMOL
Template: 2NYU, chain A
Confidence level:very confident
Coverage over the Query: 280-298,312-354,371-495
View the alignment between query and template
View the model in PyMOL
Template: 2NYU, chain A
Confidence level:very confident
Coverage over the Query: 19-170
View the alignment between query and template
View the model in PyMOL